BioNTech SE (BNTX) Change in Accured Expenses (2018 - 2021)

BioNTech SE has disclosed Change in Accured Expenses across 4 years of filings, most recently posting $844365.3 for Q1 2021.

• Change in Accured Expenses for Q1 2021 came in at $844365.3, up 91.22% year-over-year; the trailing twelve-month figure through Mar 2021 was -$1.6 million (changed N/A YoY), and the FY2020 annual result was $2388.2, up 25.66% from the prior year.
• Change in Accured Expenses came in at $844365.3 for Q1 2021 at BioNTech SE, up from $441575.6 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $844365.3 in Q1 2021 to a low of -$1.5 million in Q4 2018.
• The 4-year median for Change in Accured Expenses is -$488330.4 (2020), against an average of -$402109.9.
• Across the five-year window, Change in Accured Expenses grew 3.92% in 2019 and soared 91.22% in 2021, its largest moves.
• BioNTech SE's Change in Accured Expenses stood at -$1.5 million in 2018, then gained by 3.92% to -$1.4 million in 2019, then surged by 131.14% to $441575.6 in 2020, then jumped by 91.22% to $844365.3 in 2021.
• The last three Change in Accured Expenses figures came in at $844365.3 (Q1 2021), $441575.6 (Q1 2020), and -$1.4 million (Q4 2019), per Business Quant data.